<?xml version="1.0" encoding="UTF-8"?>
<p id="Par29">The clinical management and outcomes of Flu-p patients are shown in Table 
 <xref rid="Tab2" ref-type="table">2</xref>. All received antibiotics and NAI, with early NAI administrated to 35.7% (385/1079) of patients. In total, 24.3% (262/1079) of patients received systemic corticosteroids during hospitalization, whilst 23.1% (249/1079), 24.6% (265/1079) and 4.9% (53/1079) developed respiratory failure, heart failure and septic shock, respectively. In total, 17.9% (193/1079) of patients received invasive ventilation and 22.4% (242/1079) were admitted to the ICU. The 30-day mortality rates were 19.3% (208/1079). 
</p>
